Clinical Research Directory
Browse clinical research sites, groups, and studies.
Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis
Sponsor: Dorothy Bautista, MD
Summary
Allogenic plasma aliquots, used as eye drops, will provide a source of plasminogen in the treatment of ligneous conjunctivitis. The investigational product will be available through written request from the Sponsor-Investigator to Canadian Blood Services, as approved by Health Canada.
Official title: The Use of Allogenic Plasma Aliquots as a Source of Plasminogen in the Treatment of Ligneous Conjunctivitis, Clinical Trial of One Case
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
1
Start Date
2025-05
Completion Date
2025-10
Last Updated
2024-11-22
Healthy Volunteers
Yes
Conditions
Interventions
Allogenic plasma aliquots, a source of plasminogen
Plasma eye drops, a source of plasminogen
Locations (1)
Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada